ACAD CapEx to Revenue

Acadia Pharmaceuticals Inc · CapEx to Revenue

ACAD logo

ACAD CapEx to Revenue

Current (TTM)1.75%
ACAD CapEx/Revenue (0.00% → 1.75%)
High-resolution chart · PNG

ACAD capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.4377%
0.0546%
5.5132%
0%
0.2317%
1.7175%
0.333%
0.9598%
0.6501%
54.8497%
3,509.8361%
150%
53.9738%
0.0611%
0.1451%
0%
0.6407%
14.2138%
5.5063%
24.9109%
9.3261%
12.712%
24.0879%
6.0648%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.